Results 11 to 20 of about 30,781 (201)

Abstract 078: Managing Clopidogrel Resistance in Neurointervention: Surveying Current Approaches

Stroke: Vascular and Interventional Neurology, 2023
Introduction Due to the variability in patient responses to clopidogrel, adjusting antiplatelet regimen based on platelet function testing has become a widespread practice to reduce thromboembolic complications in neurointervention.
Hyun Woo Kim, Ivo Bach, Juan Carlos Martinez‐Gutierrez, Adam Dmytriw, Hussein Zeineddine, Salvatore D'Amato, Sunil Sheth   +6 more
doaj   +3 more sources

Managing Clopidogrel Resistance in Neurointervention: Surveying Current Approaches [PDF]

Stroke: Vascular and Interventional Neurology
Background Because of the variability in patient responses to clopidogrel and to reduce the risk of thromboembolic complications, adjusting the antiplatelet regimen based on platelet function testing has become a widespread practice in neurointervention.
Hyun Woo Kim, Ivo Bach, Juan Carlos Martinez Gutierrez, Adam A. Dmytriw, Salvatore D'Amato, Hussein A. Zeineddine, Albert J. Yoo, Sunil A. Sheth   +7 more
doaj   +3 more sources

Comparison of Light Transmission Aggregometry and VerifyNow in Detecting Clopidogrel Resistance and Factors Affecting Clopidogrel Resistance in AMI-EST Patients Undergoing Percutaneous Coronary Intervention: A Cross-Sectional Study

Indonesian Biomedical Journal, 2021
BACKGROUND: Light transmission aggregometry (LTA) and VerifyNow is commonly used to measure platelet responsiveness to clopidogrel. This study aimed to compare the results of LTA and VerifyNow P2Y12 assay for assessing the clopidogrel resistance in ...
Astuti Giantini, Ina Susianti Timan, Erlin Listiyaningsih, Rahajuningsih Dharma, Rianto Setiabudy, Idrus Alwi, Lia Gardenia Partakusuma, Nuri Dyah Indrasari, Alida Roswita Harahap, Siskawati Suparmin, Windy Sahar, Renan Sukmawan   +11 more
doaj   +3 more sources

RESISTANCE TO ANTIPLATELET DRUGS (ASPIRIN, CLOPIDOGREL) IN PATIENTS UNDERGOING ELECTIVE PERCUTANEOUS CORONARY INTERVENTION

Рациональная фармакотерапия в кардиологии, 2015
Aim. To study prevalence of resistance to acetylsalicylic acid, clopidogrel and dual resistance in percutaneous coronary intervention (PCI), to identify clinical risk factors of resistance development, to study effects of concomitant therapy on ...
V. A. Sulimov, E. V. Moroz
doaj   +5 more sources

Clopidogrel resistance: What's new?

Archives of Cardiovascular Diseases, 2010
The concept of clopidogrel resistance emerged several years ago. Since then, many studies have been performed to elucidate the mechanisms and potential clinical impact of this biological finding. These studies identified complex mechanisms, including drug-drug interactions, genetic polymorphisms and clinical factors, and showed consistently the ...
Cuisset, Thomas, Cayla, Guillaume, Silvain, Johanne   +2 more
openaire   +3 more sources

Resistance to clopidogrel: A review of the evidence

Journal of the American College of Cardiology, 2005
Current available data show that about 4% to 30% of patients treated with conventional doses of clopidogrel do not display adequate antiplatelet response. Clopidogrel resistance is a widely used term that remains to be clearly defined. So far, it has been used to reflect failure of clopidogrel to achieve its antiaggregatory effect.
Nguyen, Thuy Anh, Diodati, Jean G., Pharand, Chantal   +2 more
openaire   +3 more sources

Clinical importance of aspirin and clopidogrel resistance

World Journal of Cardiology, 2010
Aspirin and clopidogrel are important components of medical therapy for patients with acute coronary syndromes, for those who received coronary artery stents and in the secondary prevention of ischaemic stroke. Despite their use, a significant number of patients experience recurrent adverse ischaemic events.
Gergely, Feher, Andrea, Feher, Gabriella, Pusch, Katalin, Koltai, Antal, Tibold, Beata, Gasztonyi, Elod, Papp, Laszlo, Szapary, Gabor, Kesmarky, Kalman, Toth   +9 more
openaire   +3 more sources

Resistência ao clopidogrel: prevalência e variáveis associadas Resistance to clopidogrel: prevalence and associate variables

Arquivos Brasileiros de Cardiologia, 2012
FUNDAMENTO: A dupla terapia antiagregante plaquetária com ácido acetilsalicílico e clopidogrel é pedra angular do tratamento de pacientes submetidos a angioplastia com implante de stents coronarianos. Todavia, parte desses pacientes, a despeito do uso de
Fabrício Braga da Silva, Gustavo Luiz Gouvêa de Almeida Junior, Augusto Neno, José Kezen, Milena Spelta, Alessandra Godomiczer, Renato Villela, Bruno Hellmuth, Sergio Salles Xavier, Roberto Hugo da Costa Lins   +9 more
doaj   +4 more sources

Comparison of Clopidogrel and Ticlopidine/Ginkgo Biloba in Patients With Clopidogrel Resistance and Carotid Stenting [PDF]

Frontiers in Neurology, 2019
Background and Purpose: Patients undergoing carotid artery stenting (CAS) who show low responsiveness to clopidogrel may have a higher risk of peri-procedural embolic events.
Jong-Won Chung, Suk Jae Kim, Jaechun Hwang, Mi Ji Lee, Jun Lee, Kyung-Yul Lee, Man-Seok Park, Sang Min Sung, Keon Ha Kim, Pyoung Jeon, Oh Young Bang   +10 more
doaj   +4 more sources

Clopidogrel Resistance in Stroke Cases

Istanbul Medical Journal, 2019
Introduction:Clopidogrel treatment is one of the standard treatments in terms of reducing mortality and morbidity in patients with cerebrovascular disease diagnosed with large artery atherosclerosis. However, resistance to clopidogrel treatment is a significant problem today. In this study, we aimed to retrospectively investigate clopidogrel resistance
Nihan Çarçak, Büşra Tuğba Özmen, Zeynep Selcen Dartıcı, Ufuk Emre, Özgür Kılıçkesmez   +4 more
openaire   +3 more sources